Neurana Pharmaceuticals Competitors and Similar CompaniesClear all
Neurana Pharmaceuticals's competitors and similar companies include Keros Therapeutics, Teva Pharmaceuticals, Esteve and Harrow Health.
 Neurana Pharmaceuticals Neurana Pharmaceuticals is a company developing a treatment for acute muscle spasm. |  Keros Therapeutics Keros Therapeutics is a biotechnology company that develops therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta. |  Harrow Health Harrow Health (formerly Imprimis Pharmaceuticals) is a pharmaceutical company dedicated to delivering high quality and innovative medicines to physicians and patients at accessible prices. | |||
Founding Date | Founding Date 2013 | Founding Date 2015 | Founding Date 1901 | Founding Date 1929 | Founding Date 2012 |
Type | Type Private | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations San Diego, US HQ San Diego, US | Locations Lexington, US HQ South Wharf, AU | Locations Petah Tikva, IL HQ Villa Adelina, AR Macquarie Park, AU Minsk, BY Antwerpen, BE Sao Paulo, BR Dupnica, BG see more | Locations San Diego, US HQ Cottonwood Heights, US Irvine, US Nashville, US Roxbury Township, US | |
Employees | Employees 2 | Employees 1365% increase | Employees 37,0006% increase | Employees 1,836 | Employees 1331% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 2.3 b | Valuation ($) 20.8 b | Valuation ($) N/A | Valuation ($) 1.7 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $151k (FY, 2023) | Revenue (est.) $15.8b (FY, 2023) | Revenue (est.) N/A | Revenue (est.) $130.2m (FY, 2023) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $8.2b (FY, 2023) | Cost of goods N/A | Cost of goods $39.6m (FY, 2023) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $7.6b (FY, 2023) | Gross profit N/A | Gross profit $90.6m (FY, 2023) |
Net income | Net income N/A | Net income ($153m) (FY, 2023) | Net income ($615m) (FY, 2023) | Net income N/A | Net income ($24.4m) (FY, 2023) |
Funding | |||||
Total funding raised | Total funding raised $ 60m | Total funding raised $ 90m | Total funding raised $ 358m | Total funding raised N/A | Total funding raised $ 48.7m |
For sources of this data, please see the company profile
View Company Profiles
Keros Therapeutics
HQ
Lexington, US
Employees
136↑ 5% increase
Keros Therapeutics is a biotechnology company that develops therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta.
View company
Teva Pharmaceuticals
HQ
Petah Tikva, IL
Employees
37,000↑ 6% increase
Teva Pharmaceuticals is a global pharmaceutical company.
View company
Esteve
HQ
Barcelona, ES
Employees
1,836
Esteve is a company that manufactures and supplies pharmaceuticals.
View companyHarrow Health
HQ
San Diego, US
Employees
133↓ 1% decrease
Harrow Health (formerly Imprimis Pharmaceuticals) is a pharmaceutical company dedicated to delivering high quality and innovative medicines to physicians and patients at accessible prices.
View company